Skip to Main Content

Paper Details

Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.
J Clin Oncol
119
2016
EEC, EECs, Endometrial Cancer, Epigenetic defects, MLH1, MMR, MMR defect, MMR defects, MMR mutation, MMR protein, MMR-deficient tumors, Women, endometrioid endometrial cancer, microsatellite, patients, tumor, tumors, women
Author NameAffiliation
David TritchlerUniversity of Oklahoma Health Sciences Center, Roswell Park Cancer Institute, Stony Brook University Hospital, The Ohio State University Nilsa Ramirez, Research Institute at Nationwide Children's Hospital, Washington University School of Medicine, University of Minnesota, Penn State Milton S. Hersey Medical Center, The University of Texas MD Anderson Cancer Center, Women and Infants Hospital of Rhode Island
Nilsa C RamirezUniversity of Oklahoma Health Sciences Center, Roswell Park Cancer Institute, Stony Brook University Hospital, The Ohio State University Nilsa Ramirez, Research Institute at Nationwide Children's Hospital, Washington University School of Medicine, University of Minnesota, Penn State Milton S. Hersey Medical Center, The University of Texas MD Anderson Cancer Center, Women and Infants Hospital of Rhode Island
Kathleen M DarcyUniversity of Oklahoma Health Sciences Center, Roswell Park Cancer Institute, Stony Brook University Hospital, The Ohio State University Nilsa Ramirez, Research Institute at Nationwide Children's Hospital, Washington University School of Medicine, University of Minnesota, Penn State Milton S. Hersey Medical Center, The University of Texas MD Anderson Cancer Center, Women and Infants Hospital of Rhode Island
  • 1 - 3

Datasets